paromomycin has been researched along with Leishmania Infection in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (31.43) | 18.7374 |
1990's | 3 (8.57) | 18.2507 |
2000's | 7 (20.00) | 29.6817 |
2010's | 12 (34.29) | 24.3611 |
2020's | 2 (5.71) | 2.80 |
Authors | Studies |
---|---|
Chandra, N; Gupta, S; Suryawanshi, SN; Tiwari, A | 1 |
Lombardo, M; Ortalli, M; Quintavalla, A; Rosso, C; Trombini, C; Varani, S | 1 |
Carneiro, SP; Registre, C; Rubio, KTS; Santos, ODH; Soares, RDOA | 1 |
Croft, SL; Loiseau, PM; Pomel, S | 1 |
de Paula, E; Giorgio, S; Ortega, V | 1 |
Caljon, G; Cos, P; Delputte, P; Gielis, JF; Hendrickx, S; Maes, L; Van Bockstal, L; Van den Kerkhof, M | 1 |
Asgari, Q; Esfandiari, F; Heli, H; Molaei, M; Morowvat, MH; Motazedian, MH | 1 |
Athanasiou, LV; Batzias, GC; Delis, G; Kontos, VI; Rallis, TS; Saridomichelakis, MN; Soubasis, N | 1 |
Doroud, D; Habibzadeh, S; Heidari-Kharaji, M; Rafati, S; Taheri, T | 1 |
Badirzadeh, A; Doroud, D; Habibzadeh, S; Heidari-Kharaji, M; Rafati, S; Taheri, T | 1 |
Davidov, G; El-On, J; Enav, H; Golan-Goldhirsh, A; Gopas, J; Luft, N; Ozer, L; Sneir, R | 1 |
Liarte, DB; Murta, SM | 1 |
Barragán, P; López-Velez, R; Olmo, M; Podzamczer, D | 1 |
Aguiar, MG; Fernandes, AP; Ferreira, LA; Pereira, AM | 1 |
Kumar, M; Singh, N; Singh, RK | 1 |
Berman, J | 2 |
Desjeux, P | 1 |
Croft, SL; Seifert, K; Yardley, V | 1 |
Chakravarty, J; Sundar, S | 1 |
Armas, JA; Moreno, G; Rezzano, S; Scorza, JV | 1 |
Abu-Elheiga, L; Bachrach, U; Schnur, LF | 1 |
Belloli, C; Carli, S; Ceci, L; De Natale, G; Marcotrigiano, G; Montesissa, C; Ormas, P; Tassi, P | 1 |
Cook, GC | 1 |
Balaña-Fouce, R; Cubría, JC; Ordóñez, D; Reguera, RM | 1 |
Carvalho, FA; Castro, GA; Fernandes, AP; Ferreira, LA; Gazzinelli, RT; Santiago, HC; Tafuri, WL; Tavares, CA | 1 |
Alexander, J; Baillie, AJ; Carter, KC | 1 |
Avinoach, I; El-On, J; Kuperman, O; Lang, E | 1 |
el-On, J; Hamburger, AD | 1 |
el-On, J; Katz, M; Weinrauch, L | 1 |
El-On, J; Even-Paz, Z; Hamburger, D; Livshin, R; Weinrauch, L | 1 |
el-On, J; Even-Paz, Z; Jacobs, GP; Livshin, R; Weinrauch, L | 1 |
el-On, J; Livshin, R; Paz, ZE; Weinrauch, L | 1 |
El-On, J; Schnur, LF; Witztum, A | 1 |
Neal, RA | 1 |
9 review(s) available for paromomycin and Leishmania Infection
Article | Year |
---|---|
A Systematic Review of Drug-Carrying Nanosystems Used in the Treatment of Leishmaniasis.
Topics: Antiprotozoal Agents; Humans; Leishmaniasis; Paromomycin; Pentamidine; Pharmaceutical Preparations | 2023 |
Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Betulinic Acid; Biocompatible Materials; Chitosan; Curcumin; Drug Carriers; Drug Compounding; Humans; Hydrogen-Ion Concentration; Leishmaniasis; Leishmaniasis Vaccines; Macrophages; Nanoparticles; Paromomycin; Pentacyclic Triterpenes; Polymers; Rifampin; Selenium; Thiomalates; Titanium; Triterpenes; Ursolic Acid | 2020 |
Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Leishmaniasis; Liposomes; Nanoparticles; Paromomycin; Particle Size; Pentamidine; Phosphorylcholine; Surface Properties | 2017 |
Leishmaniasis: current status of available drugs and new potential drug targets.
Topics: Aminoquinolines; Amphotericin B; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Caspase Inhibitors; Cyclin-Dependent Kinases; Drug Discovery; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Leishmaniasis; Macrophages; Microbodies; Mitogen-Activated Protein Kinase Kinases; Paromomycin; Pentamidine; Phosphorylcholine; Polyamines; Protease Inhibitors; Sterols; Sulfhydryl Compounds; Topoisomerase Inhibitors | 2012 |
Current treatment approaches to leishmaniasis.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Fluconazole; Humans; Leishmaniasis; Paromomycin; Pentamidine; Phosphorylcholine | 2003 |
Clinical status of agents being developed for leishmaniasis.
Topics: Aminoquinolines; Antiprotozoal Agents; Fluconazole; Humans; Imiquimod; Ketoconazole; Leishmaniasis; Paromomycin; Phosphorylcholine | 2005 |
Current scenario of drug development for leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Design; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Models, Chemical; Paromomycin; Phosphorylcholine | 2006 |
Paromomycin in the treatment of leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Clinical Trials as Topic; Humans; Leishmania; Leishmaniasis; Molecular Structure; Paromomycin | 2008 |
The pharmacology of leishmaniasis.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Drug Design; Humans; Itraconazole; Ketoconazole; Leishmania; Leishmaniasis; Paromomycin; World Health Organization | 1998 |
26 other study(ies) available for paromomycin and Leishmania Infection
Article | Year |
---|---|
Chemotherapy of leishmaniasis. Part XI: synthesis and bioevaluation of novel isoxazole containing heteroretinoid and its amide derivatives.
Topics: Amides; Animals; Antiprotozoal Agents; Cricetinae; Female; Isoxazoles; Leishmania donovani; Leishmaniasis; Male; Molecular Structure; Retinoids | 2012 |
Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.
Topics: Animals; Chlorocebus aethiops; Dioxanes; Drug Design; Humans; Leishmania; Leishmaniasis; Parasitic Sensitivity Tests; Trypanocidal Agents; Vero Cells | 2019 |
Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; Drug Resistance; Female; Interleukin-6; Leishmania infantum; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitric Oxide; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2018 |
Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis.
Topics: Animals; Chitosan; Drug Delivery Systems; Leishmaniasis; Nanoparticles; Paromomycin; Spectroscopy, Fourier Transform Infrared | 2019 |
Pharmacokinetics and tolerability of aminosidine after repeated administrations using an optimal dose regimen in healthy dogs and in dogs with leishmaniosis.
Topics: Animals; Chromatography, High Pressure Liquid; Dog Diseases; Dogs; Drug Administration Schedule; Female; Half-Life; Injections, Subcutaneous; Leishmania; Leishmaniasis; Male; Paromomycin | 2014 |
Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Carriers; Female; Interferon-gamma; Interleukin-4; Leishmania tropica; Leishmaniasis; Mice; Mice, Inbred BALB C; Nanoparticles; Nitric Oxide; Paromomycin; Th1 Cells | 2016 |
Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model.
Topics: Animals; Antiprotozoal Agents; Cytokines; Disease Models, Animal; Drug Carriers; Drug Compounding; Female; Interferon-gamma; Interleukin-4; Leishmania; Leishmaniasis; Lipids; Mice; Mice, Inbred BALB C; Nanoparticles; Nitric Oxide; Paromomycin | 2016 |
Antileishmanial activity in Israeli plants.
Topics: Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Humans; Israel; Leishmania major; Leishmaniasis; Life Cycle Stages; Macrophages; Male; Mice; Mice, Inbred C3H; Nuphar; Paromomycin; Phytotherapy; Plant Extracts; Withania | 2009 |
Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species.
Topics: Amphotericin B; Animals; Antimony Potassium Tartrate; Antiprotozoal Agents; Culture Media; Drug Resistance; Inhibitory Concentration 50; Leishmania; Leishmaniasis; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Paromomycin; Phenotype; Phosphorylcholine; Selection, Genetic; Serial Passage; Spleen; Virulence | 2010 |
Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.
Topics: AIDS-Related Opportunistic Infections; HIV; HIV Infections; HIV-1; Humans; Itraconazole; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Opportunistic Infections; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Recurrence; Treatment Failure | 2010 |
Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Female; Leishmania; Leishmaniasis; Mice; Mice, Inbred BALB C; Paromomycin; Phosphorylcholine; Skin | 2010 |
Leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Humans; Insect Control; Leishmania; Leishmaniasis; Paromomycin; Phosphorylcholine; Protozoan Vaccines | 2004 |
[Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Sex Factors | 1984 |
Leishmania tropica major: effect of paromomycin and pentamidine on polyamine levels in the skin of normal and infected mice.
Topics: Adenosylmethionine Decarboxylase; Amidines; Animals; Drug Evaluation, Preclinical; Leishmaniasis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Ornithine Decarboxylase; Paromomycin; Pentamidine; Polyamines; Putrescine; Skin; Spermidine; Spermine; Time Factors | 1983 |
Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Interactions; Female; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Models, Biological; Organometallic Compounds; Paromomycin | 1995 |
Leishmaniasis: some recent developments in chemotherapy.
Topics: Allopurinol; Amphotericin B; Antiprotozoal Agents; Humans; Ketoconazole; Leishmaniasis; Paromomycin | 1993 |
Combined interleukin-12 and topical chemotherapy for established Leishmaniasis drastically reduces tissue parasitism and relapses in susceptible mice.
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Interferon-gamma; Interleukin-12; Interleukin-4; Leishmania major; Leishmaniasis; Mice; Mice, Inbred BALB C; Paromomycin; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2001 |
Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzethonium chloride and the aminoglycosides, gentamicin and paromomycin.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Benzethonium; Female; Gentamicins; Leishmaniasis; Male; Mice; Mice, Inbred BALB C; Ointments; Paromomycin; Quaternary Ammonium Compounds | 1989 |
Leishmania major: histopathological responses before and after topical treatment in experimental animals.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Benzethonium; Collagen; Drug Combinations; Female; Leishmania tropica; Leishmaniasis; Lymphocytes; Macrophages; Mast Cells; Mice; Mice, Inbred BALB C; Neutrophils; Ointments; Paromomycin; Quaternary Ammonium Compounds; Skin | 1989 |
Topical treatment of New and Old World cutaneous leishmaniasis in experimental animals.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Benzethonium; Drug Combinations; Leishmania braziliensis; Leishmania mexicana; Leishmania tropica; Leishmaniasis; Male; Mice; Mice, Inbred BALB C; Paromomycin; Quaternary Ammonium Compounds | 1987 |
Leishmania aethiopica: topical treatment with paromomycin and methylbenzethonium chloride ointment.
Topics: Adult; Benzethonium; Child; Drug Combinations; Female; Humans; Leishmaniasis; Male; Paromomycin; Quaternary Ammonium Compounds | 1987 |
Topical treatment of cutaneous leishmaniasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Benzethonium; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Leishmaniasis; Male; Middle Aged; Ointments; Paromomycin | 1986 |
Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.
Topics: Administration, Topical; Anti-Infective Agents, Local; Benzethonium; Female; Humans; Leishmania tropica; Leishmaniasis; Male; Middle Aged; Ointments; Paromomycin; Quaternary Ammonium Compounds; Recurrence | 1985 |
Topical treatment of cutaneous leishmaniasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Animals; Benzethonium; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Leishmaniasis; Male; Mice; Middle Aged; Ointments; Paromomycin; Quaternary Ammonium Compounds | 1985 |
Protection of guinea pigs against cutaneous leishmaniasis by combined infection and chemotherapy.
Topics: Animals; Antibodies; Benzethonium; Drug Combinations; Guinea Pigs; Leishmaniasis; Ointments; Paromomycin; Quaternary Ammonium Compounds; Vaccination | 1986 |
The effect of antibiotics of the neomycin group on experimental cutaneous leishmaniasis.
Topics: Animals; Anthelmintics; Anti-Bacterial Agents; Framycetin; Kanamycin; Leishmaniasis; Mice; Neomycin; Paromomycin | 1968 |